External use of mirabilite to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis in children: A multicenter randomized controlled trial

Table 6 The levels of serum D-lactate, endotoxin and diamine oxidase in each group (MP 25, P75 ug/L)

		External use of mirabilite group (n = 117)	Blank group (n = 117)	P value
D-lactate	Pre-ERCP 3 h	190.65 (164.37, 273.58)	224.38 (187.29, 313.58)	0.120
	Post-ERCP 24 h	199.73 (180.57, 233.96)	213.88 (192.04, 314.86)	0.078
	P value	0.849	0.914
Endotoxin	Pre-ERCP 3 h	5.95 (4.06, 7.83)	5.21 (3.94, 6.91)	0.375
	Post-ERCP 24 h	5.36 (4.09, 8.01)	5.35 (4.50, 7.89)	0.874
	P value	0.762	0.559
DAO	Pre-ERCP 3 h	0.65 (0.44, 2.47)	0.63 (0.51, 0.97)	0.635
	Post-ERCP 24 h	1.04 (0.52, 2.47)	0.79 (0.585, 0.79)	0.536
	P value	0.410	0.129

DAO: Diamine oxidase; ERCP: Endoscopic retrograde cholangiopancreatography pancreatitis.